<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">2195</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"/><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>SUSTAINED INTRANASAL DRUG DELIVARY SYSTEM FOR THE TREATMENT OF GASTROPARESIS&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>V.A.</surname><given-names>Agrawal</given-names></name></contrib><contrib contrib-type="author"><name><surname>R.M</surname><given-names>Rajurkar</given-names></name></contrib><contrib contrib-type="author"><name><surname>A.M</surname><given-names>Mahle</given-names></name></contrib><contrib contrib-type="author"><name><surname>S.S.</surname><given-names>Thonte</given-names></name></contrib></contrib-group><volume/><issue/><fpage>4</fpage><lpage>12</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>The present investigation concerns about the development of the colloidal dispersion of&#13;
mucoadhesive polymers containing Domperidone for intranasal delivery. Colloidal&#13;
dispersion was prepared by sonication method and was characterized. Methylcellulose,&#13;
Hydroxypropyl methylcellulose and Chitosan were used as a release retardant material.&#13;
The nasal isotonic buffer was prepared after calculating the Sodium chloride&#13;
displacement (E value) of the ingredients and was used as a vehicle. E values were&#13;
calculated from L iso values. The effects of HPMC and Chitosan on drug release&#13;
profile were investigated. In the study it was found that HPMC has synergistic effect on&#13;
viscosity and bioadhesive strength when used in combination with methyl cellulose.&#13;
Formulations were evaluated for in vitro drug release profile, Appearance, pH&#13;
examination, Drug content estimation In-vitro Bioadhesion studies at different contact&#13;
times, for selection of the best batch. Formulation batch F2 was the optimized and was&#13;
further studied for Histopathological examination and accelerated stability.&#13;
</p></abstract><kwd-group><kwd>Colloidal dispersion</kwd><kwd> nasal isotonic buffer</kwd><kwd> E value</kwd><kwd> bioadhesion.</kwd></kwd-group></article-meta></front></article>
